Pharma 4.0

CSL’s Broadmeadows facility in Australia has won the ISPE’s 2025 Facility of the Year Award as Overall Winner. The plasma fractionation plant is recognized for its Pharma 4.0 integration, pioneering hybrid manufacturing platform, and sustainable design. Advanced automation, real-time monitoring, robotics, and a digital twin infrastructure contribute to increased plasma processing capacity and efficiency. The facility’s sustainable features include reusable filters and energy-efficient systems. The award acknowledges CSL’s commitment to innovation, operational excellence, and environmental responsibility.